Global Immuno-oncology Drugs Professional Survey Report 2022, Forecast to 2027

Code: RW00014838685
Multimarket Insight
Sep-2022
Life Sciences
139 Pages

Immuno-oncology is?the study and development of treatments that take advantage of the body's immune system to fight cancer.?
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Immuno-oncology Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy

Market Segment by Product Application
Hospitals
Pharmacies
Online Pharmacies

Finally, the report provides detailed profile and data information analysis of leading company.
Amgen, Inc
Johnson & Johnson
Celgene Corporation
AstraZeneca, Plc
Hoffmann-La Roche AG
Bristol-Myers Squibb
AbbVie, Inc.
Merck & Co.
Eli Lilly and Company
Novartis International AG
Prometheus Therapeutics & Diagnostics
Bavarian Nordic
Pfizer Inc.
ImmunoCellular Therapeutics
Aduro BioTech
Gilead Sciences Inc.
Sanofi S.A.
Celldex Therapeutics
Galena Biopharma
EMD Serono, Inc.
Incyte

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Immuno-oncology Drugs consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Immuno-oncology Drugs market by identifying its various subsegments.
3.Focuses on the key global Immuno-oncology Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Immuno-oncology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Immuno-oncology Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Immuno-oncology Drugs Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Immuno-oncology Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Immuno-oncology Drugs Segment by Type
2.1.1 Immune Checkpoint Inhibitors
2.1.2 Monoclonal Antibodies
2.1.3 Cytokine-Based Immunotherapy
2.1.4 Cancer Vaccines
2.1.5 CAR-T Cell Therapy
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Pharmacies
2.2.3 Online Pharmacies
2.3 Global Immuno-oncology Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global Immuno-oncology Drugs Market Size (2017-2027)
2.3.2 North America Immuno-oncology Drugs Status and Prospect (2017-2027)
2.3.3 Europe Immuno-oncology Drugs Status and Prospect (2017-2027)
2.3.4 Asia-pacific Immuno-oncology Drugs Status and Prospect (2017-2027)
2.3.5 South America Immuno-oncology Drugs Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Immuno-oncology Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Immuno-oncology Drugs Industry Impact
2.5.1 Immuno-oncology Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Immuno-oncology Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Immuno-oncology Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Immuno-oncology Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Immuno-oncology Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Immuno-oncology Drugs Manufacturer Market Share
3.5 Top 10 Immuno-oncology Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Immuno-oncology Drugs Market
3.7 Key Manufacturers Immuno-oncology Drugs Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Immuno-oncology Drugs Industry Key Manufacturers
4.1 Amgen, Inc
4.1.1 Company Details
4.1.2 Amgen, Inc Immuno-oncology Drugs Product Introduction, Application and Specification
4.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Amgen, Inc News
4.2 Johnson & Johnson
4.2.1 Company Details
4.2.2 Johnson & Johnson Immuno-oncology Drugs Product Introduction, Application and Specification
4.2.3 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Johnson & Johnson News
4.3 Celgene Corporation
4.3.1 Company Details
4.3.2 Celgene Corporation Immuno-oncology Drugs Product Introduction, Application and Specification
4.3.3 Celgene Corporation Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Celgene Corporation News
4.4 AstraZeneca, Plc
4.4.1 Company Details
4.4.2 AstraZeneca, Plc Immuno-oncology Drugs Product Introduction, Application and Specification
4.4.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 AstraZeneca, Plc News
4.5 Hoffmann-La Roche AG
4.5.1 Company Details
4.5.2 Hoffmann-La Roche AG Immuno-oncology Drugs Product Introduction, Application and Specification
4.5.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Hoffmann-La Roche AG News
4.6 Bristol-Myers Squibb
4.6.1 Company Details
4.6.2 Bristol-Myers Squibb Immuno-oncology Drugs Product Introduction, Application and Specification
4.6.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Bristol-Myers Squibb News
4.7 AbbVie, Inc.
4.7.1 Company Details
4.7.2 AbbVie, Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.7.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 AbbVie, Inc. News
4.8 Merck & Co.
4.8.1 Company Details
4.8.2 Merck & Co. Immuno-oncology Drugs Product Introduction, Application and Specification
4.8.3 Merck & Co. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Merck & Co. News
4.9 Eli Lilly and Company
4.9.1 Company Details
4.9.2 Eli Lilly and Company Immuno-oncology Drugs Product Introduction, Application and Specification
4.9.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Eli Lilly and Company News
4.10 Novartis International AG
4.10.1 Company Details
4.10.2 Novartis International AG Immuno-oncology Drugs Product Introduction, Application and Specification
4.10.3 Novartis International AG Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Novartis International AG News
4.11 Prometheus Therapeutics & Diagnostics
4.11.1 Company Details
4.11.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Introduction, Application and Specification
4.11.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Prometheus Therapeutics & Diagnostics News
4.12 Bavarian Nordic
4.12.1 Company Details
4.12.2 Bavarian Nordic Immuno-oncology Drugs Product Introduction, Application and Specification
4.12.3 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Bavarian Nordic News
4.13 Pfizer Inc.
4.13.1 Company Details
4.13.2 Pfizer Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.13.3 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Pfizer Inc. News
4.14 ImmunoCellular Therapeutics
4.14.1 Company Details
4.14.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Introduction, Application and Specification
4.14.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 ImmunoCellular Therapeutics News
4.15 Aduro BioTech
4.15.1 Company Details
4.15.2 Aduro BioTech Immuno-oncology Drugs Product Introduction, Application and Specification
4.15.3 Aduro BioTech Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Aduro BioTech News
4.16 Gilead Sciences Inc.
4.16.1 Company Details
4.16.2 Gilead Sciences Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.16.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Gilead Sciences Inc. News
4.17 Sanofi S.A.
4.17.1 Company Details
4.17.2 Sanofi S.A. Immuno-oncology Drugs Product Introduction, Application and Specification
4.17.3 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Sanofi S.A. News
4.18 Celldex Therapeutics
4.18.1 Company Details
4.18.2 Celldex Therapeutics Immuno-oncology Drugs Product Introduction, Application and Specification
4.18.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Celldex Therapeutics News
4.19 Galena Biopharma
4.19.1 Company Details
4.19.2 Galena Biopharma Immuno-oncology Drugs Product Introduction, Application and Specification
4.19.3 Galena Biopharma Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Galena Biopharma News
4.20 EMD Serono, Inc.
4.20.1 Company Details
4.20.2 EMD Serono, Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.20.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 EMD Serono, Inc. News
4.21 Incyte
4.21.1 Company Details
4.21.2 Incyte Immuno-oncology Drugs Product Introduction, Application and Specification
4.21.3 Incyte Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.21.4 Main Business Overview
4.21.5 Incyte News

5 Global Immuno-oncology Drugs Sales Categorized by Regions
5.1 Global Immuno-oncology Drugs Revenue, Sales and Market Share by Regions
5.1.1 Global Immuno-oncology Drugs Sales and Market Share by Regions (2017-2022)
5.1.2 Global Immuno-oncology Drugs Revenue and Market Share by Regions (2017-2022)
5.2 North America Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
5.3 Europe Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
5.5 South America Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Immuno-oncology Drugs Sales and Growth Rate (2017-2022)

6 North America Immuno-oncology Drugs Market Size Categorized by Countries
6.1 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
6.1.1 North America Immuno-oncology Drugs Sales (Volume) by Countries (2017-2022)
6.1.2 North America Immuno-oncology Drugs Revenue by Countries (2017-2022)
6.1.3 United States Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
6.1.4 Canada Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
6.1.5 Mexico Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
6.2 North America Immuno-oncology Drugs Revenue (Value) by Manufacturers
6.3 North America Immuno-oncology Drugs Sales and Market Share by Type (2017-2022)
6.4 North America Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

7 Europe Immuno-oncology Drugs Market Size Categorized by Countries
7.1 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
7.1.1 Europe Immuno-oncology Drugs Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Immuno-oncology Drugs Revenue by Countries (2017-2022)
7.1.3 Germany Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
7.1.4 UK Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
7.1.5 France Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
7.1.6 Russia Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
7.1.7 Italy Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
7.1.8 Spain Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
7.2 Europe Immuno-oncology Drugs Revenue (Value) by Manufacturers
7.3 Europe Immuno-oncology Drugs Sales and Market Share by Type (2017-2022)
7.4 Europe Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

8 Asia-Pacific Immuno-oncology Drugs Market Size Categorized by Countries
8.1 Asia-pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Immuno-oncology Drugs Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Immuno-oncology Drugs Revenue by Countries (2017-2022)
8.1.3 China Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
8.1.4 South Korea Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
8.1.5 Japan Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
8.1.6 Australia Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
8.1.7 India Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Immuno-oncology Drugs Revenue (Value) by Manufacturers
8.3 Asia-pacific Immuno-oncology Drugs Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

9 South America Immuno-oncology Drugs Market Size Categorized by Countries
9.1 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
9.1.1 South America Immuno-oncology Drugs Sales (Volume) by Countries (2017-2022)
9.1.2 South America Immuno-oncology Drugs Revenue by Countries (2017-2022)
9.1.3 Brazil Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
9.2 South America Immuno-oncology Drugs Sales and Market Share by Type (2017-2022)
9.3 South America Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

10 Middle East and Africa Immuno-oncology Drugs Market Size Categorized by Countries
10.1 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Immuno-oncology Drugs Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Immuno-oncology Drugs Revenue by Countries (2017-2022)
10.1.3 GCC Countries Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
10.1.4 Turkey Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
10.1.5 Egypt Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
10.1.6 South America Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Immuno-oncology Drugs Sales and Market Share by Type
10.3 Middle East and Africa Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

11 Global Immuno-oncology Drugs Market Segment by Type
11.1 Global Immuno-oncology Drugs Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Immuno-oncology Drugs Sales and Market Share by Type (2017-2022)
11.1.2 Global Immuno-oncology Drugs Revenue and Market Share by Type (2017-2022)
11.2 Immune Checkpoint Inhibitors Sales Growth Rate and Price
11.2.1 Global Immune Checkpoint Inhibitors Sales Growth Rate (2017-2022)
11.2.2 Global Immune Checkpoint Inhibitors Price (2017-2022)
11.3 Monoclonal Antibodies Sales Growth Rate and Price
11.3.1 Global Monoclonal Antibodies Sales Growth Rate (2017-2022)
11.3.2 Global Monoclonal Antibodies Price (2017-2022)
11.4 Cytokine-Based Immunotherapy Sales Growth Rate and Price
11.4.1 Global Cytokine-Based Immunotherapy Sales Growth Rate (2017-2022)
11.4.2 Global Cytokine-Based Immunotherapy Price (2017-2022)
11.5.1 Global Cancer Vaccines Sales Growth Rate (2017-2022)
11.5.2 Global Cancer Vaccines Price (2017-2022)
11.6 CAR-T Cell Therapy Sales Growth Rate and Price
11.6.1 Global CAR-T Cell Therapy Sales Growth Rate (2017-2022)
11.6.2 Global CAR-T Cell Therapy Price (2017-2022)

12 Global Immuno-oncology Drugs Market Segment by Application
12.1 Global Immuno-oncology Drugs Sales Market Share by Application (2017-2022)
12.2 Hospitals Sales Growth Rate (2017-2022)
12.3 Pharmacies Sales Growth Rate (2017-2022)
12.4 Online Pharmacies Sales Growth Rate (2017-2022)

13 Global Immuno-oncology Drugs Market Forecast
13.1 Global Immuno-oncology Drugs Revenue, Sales and Growth Rate (2022-2027)
13.2 Immuno-oncology Drugs Market Forecast by Regions (2022-2027)
13.2.1 North America Immuno-oncology Drugs Market Forecast (2022-2027)
13.2.2 Europe Immuno-oncology Drugs Market Forecast (2022-2027)
13.2.3 Asia-Pacific Immuno-oncology Drugs Market Forecast (2022-2027)
13.2.4 South America Immuno-oncology Drugs Market Forecast (2022-2027)
13.2.5 Middle East & Africa Immuno-oncology Drugs Market Forecast (2022-2027)
13.3 Immuno-oncology Drugs Market Forecast by Type (2022-2027)
13.3.1 Global Immuno-oncology Drugs Sales Forecast by Type (2022-2027)
13.3.2 Global Immuno-oncology Drugs Market Share Forecast by Type (2022-2027)
13.4 Immuno-oncology Drugs Market Forecast by Application (2022-2027)
13.4.1 Global Immuno-oncology Drugs Sales Forecast by Application (2022-2027)
13.4.2 Global Immuno-oncology Drugs Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Immuno-oncology Drugs Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Immuno-oncology Drugs Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture Immuno-oncology Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Immuno-oncology Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Immuno-oncology Drugs Market Size by Type
Figure Global Market Share of Immuno-oncology Drugs by Type in 2021
Figure Immune Checkpoint Inhibitors Picture
Figure Monoclonal Antibodies Picture
Figure Cytokine-Based Immunotherapy Picture
Figure Cancer Vaccines Picture
Figure CAR-T Cell Therapy Picture
Table Global Immuno-oncology Drugs Market Size (Volume) by Application
Figure Hospitals Picture
Figure Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Immuno-oncology Drugs Comparison by Regions (M USD) 2017-2027
Figure Global Immuno-oncology Drugs Market Size (Million US$) (2017-2027)
Figure North America Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Immuno-oncology Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Immuno-oncology Drugs Sales by Manufacturer (2017-2022)
Figure Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2021
Table Global Immuno-oncology Drugs Revenue by Manufacturer (2017-2022)
Figure Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2021
Table Global Immuno-oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Immuno-oncology Drugs Market
Table Key Manufacturers Immuno-oncology Drugs Product Type
Table Mergers & Acquisitions Planning
Table Amgen, Inc Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Amgen, Inc
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Amgen, Inc 2017-2022
Table Amgen, Inc Main Business
Table Amgen, Inc Recent Development
Table Johnson & Johnson Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Johnson & Johnson
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Celgene Corporation Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Celgene Corporation
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celgene Corporation 2017-2022
Table Celgene Corporation Main Business
Table Celgene Corporation Recent Development
Table AstraZeneca, Plc Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of AstraZeneca, Plc
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca, Plc 2017-2022
Table AstraZeneca, Plc Main Business
Table AstraZeneca, Plc Recent Development
Table Hoffmann-La Roche AG Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Hoffmann-La Roche AG
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hoffmann-La Roche AG 2017-2022
Table Hoffmann-La Roche AG Main Business
Table Hoffmann-La Roche AG Recent Development
Table Bristol-Myers Squibb Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2017-2022
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table AbbVie, Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of AbbVie, Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie, Inc. 2017-2022
Table AbbVie, Inc. Main Business
Table AbbVie, Inc. Recent Development
Table Merck & Co. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Merck & Co.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck & Co. 2017-2022
Table Merck & Co. Main Business
Table Merck & Co. Recent Development
Table Eli Lilly and Company Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Eli Lilly and Company
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly and Company 2017-2022
Table Eli Lilly and Company Main Business
Table Eli Lilly and Company Recent Development
Table Novartis International AG Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Novartis International AG
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis International AG 2017-2022
Table Novartis International AG Main Business
Table Novartis International AG Recent Development
Table Prometheus Therapeutics & Diagnostics Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Prometheus Therapeutics & Diagnostics
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Prometheus Therapeutics & Diagnostics 2017-2022
Table Prometheus Therapeutics & Diagnostics Main Business
Table Prometheus Therapeutics & Diagnostics Recent Development
Table Bavarian Nordic Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Bavarian Nordic
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bavarian Nordic 2017-2022
Table Bavarian Nordic Main Business
Table Bavarian Nordic Recent Development
Table Pfizer Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Pfizer Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer Inc. 2017-2022
Table Pfizer Inc. Main Business
Table Pfizer Inc. Recent Development
Table ImmunoCellular Therapeutics Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of ImmunoCellular Therapeutics
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ImmunoCellular Therapeutics 2017-2022
Table ImmunoCellular Therapeutics Main Business
Table ImmunoCellular Therapeutics Recent Development
Table Aduro BioTech Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Aduro BioTech
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Aduro BioTech 2017-2022
Table Aduro BioTech Main Business
Table Aduro BioTech Recent Development
Table Gilead Sciences Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Gilead Sciences Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Gilead Sciences Inc. 2017-2022
Table Gilead Sciences Inc. Main Business
Table Gilead Sciences Inc. Recent Development
Table Sanofi S.A. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Sanofi S.A.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi S.A. 2017-2022
Table Sanofi S.A. Main Business
Table Sanofi S.A. Recent Development
Table Celldex Therapeutics Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Celldex Therapeutics
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celldex Therapeutics 2017-2022
Table Celldex Therapeutics Main Business
Table Celldex Therapeutics Recent Development
Table Galena Biopharma Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Galena Biopharma
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Galena Biopharma 2017-2022
Table Galena Biopharma Main Business
Table Galena Biopharma Recent Development
Table EMD Serono, Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of EMD Serono, Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of EMD Serono, Inc. 2017-2022
Table EMD Serono, Inc. Main Business
Table EMD Serono, Inc. Recent Development
Table Incyte Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Incyte
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Incyte 2017-2022
Table Incyte Main Business
Table Incyte Recent Development
Figure Global Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Global Immuno-oncology Drugs Revenue and Growth Rate (2017-2022)
Table Global Immuno-oncology Drugs Sales by Regions (2017-2022)
Figure Global Immuno-oncology Drugs Sales Market Share by Regions in 2021
Table Global Immuno-oncology Drugs Revenue by Regions (2017-2022)
Figure Global Immuno-oncology Drugs Revenue Market Share by Regions in 2021
Figure North America Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Europe Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Asia-pacific Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure South America Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure North America Immuno-oncology Drugs Revenue and Growth Rate (2017-2022)
Table North America Immuno-oncology Drugs Sales (Volume) by Countries (2017-2022)
Table North America Immuno-oncology Drugs Sales Market Share by Countries (2017-2022)
Figure North America Immuno-oncology Drugs Sales Market Share by Countries in 2021
Table North America Immuno-oncology Drugs Revenue by Countries (2017-2022)
Table North America Immuno-oncology Drugs Revenue Market Share by Countries (2017-2022)
Figure North America Immuno-oncology Drugs Revenue Market Share by Countries in 2021
Figure United States Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Canada Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Mexico Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Table North America Immuno-oncology Drugs Revenue by Manufacturer (2021)
Figure North America Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2021
Table North America Immuno-oncology Drugs Sales by Type (2017-2022)
Table North America Immuno-oncology Drugs Sales Share by Type (2017-2022)
Table North America Immuno-oncology Drugs Sales by Application (2017-2022)
Table North America Immuno-oncology Drugs Sales Share by Application (2017-2022)
Figure Europe Immuno-oncology Drugs Revenue and Growth Rate (2017-2022)
Table Europe Immuno-oncology Drugs Sales (Volume) by Countries (2017-2022)
Table Europe Immuno-oncology Drugs Sales Market Share by Countries (2017-2022)
Figure Europe Immuno-oncology Drugs Sales Market Share by Countries in 2021
Table Europe Immuno-oncology Drugs Revenue by Countries (2017-2022)
Table Europe Immuno-oncology Drugs Revenue Market Share by Countries (2017-2022)
Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2021
Figure Germany Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure UK Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure France Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Russia Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Italy Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Spain Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Table Europe Immuno-oncology Drugs Revenue by Manufacturer (2021)
Figure Europe Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2021
Table Europe Immuno-oncology Drugs Sales by Type (2017-2022)
Table Europe Immuno-oncology Drugs Sales Share by Type (2017-2022)
Table Europe Immuno-oncology Drugs Sales by Application (2017-2022)
Table Europe Immuno-oncology Drugs Sales Share by Application (2017-2022)
Figure Asia-pacific Immuno-oncology Drugs Revenue and Growth Rate (2017-2022)
Table Asia-pacific Immuno-oncology Drugs Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Immuno-oncology Drugs Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Immuno-oncology Drugs Sales Market Share by Countries in 2021
Table Asia-pacific Immuno-oncology Drugs Revenue by Countries (2017-2022)
Table Asia-pacific Immuno-oncology Drugs Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Immuno-oncology Drugs Revenue Market Share by Countries in 2021
Figure China Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure South Korea Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Japan Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Australia Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure India Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Table Asia-pacific Immuno-oncology Drugs Revenue by Manufacturer (2021)
Figure Asia-pacific Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Immuno-oncology Drugs Sales by Type (2017-2022)
Table Asia-pacific Immuno-oncology Drugs Sales Share by Type (2017-2022)
Table Asia-pacific Immuno-oncology Drugs Sales by Application (2017-2022)
Table Asia-pacific Immuno-oncology Drugs Sales Share by Application (2017-2022)
Figure South America Immuno-oncology Drugs Revenue and Growth Rate (2017-2022)
Table South America Immuno-oncology Drugs Sales (Volume) by Countries (2017-2022)
Table South America Immuno-oncology Drugs Sales Market Share by Countries (2017-2022)
Figure South America Immuno-oncology Drugs Sales Market Share by Countries in 2019
Table South America Immuno-oncology Drugs Revenue by Countries (2017-2022)
Table South America Immuno-oncology Drugs Revenue Market Share by Countries (2017-2022)
Figure South America Immuno-oncology Drugs Revenue Market Share by Countries in 2019
Figure Brazil Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Table South America Immuno-oncology Drugs Sales by Type (2017-2022)
Table South A

Amgen, Inc
Johnson & Johnson
Celgene Corporation
AstraZeneca, Plc
Hoffmann-La Roche AG
Bristol-Myers Squibb
AbbVie, Inc.
Merck & Co.
Eli Lilly and Company
Novartis International AG
Prometheus Therapeutics & Diagnostics
Bavarian Nordic
Pfizer Inc.
ImmunoCellular Therapeutics
Aduro BioTech
Gilead Sciences Inc.
Sanofi S.A.
Celldex Therapeutics
Galena Biopharma
EMD Serono, Inc.
Incyte

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE